Study project for the case registration of Tenghuangjiangu tablets in the treatment to osteoarthritis of the knee

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900026262

Enrollment

Unknown

Registered

2019-09-28

Start date

2019-09-27

Completion date

Unknown

Last updated

2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of the Knee

Interventions

1:Tenghuangjiangu tablets

2:Western medicine routine treatment

Eligibility

Sex/Gender

All

Age

50 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. It conforms to the diagnostic criteria of knee osteoarthritis formulated by the Guidelines for Diagnosis and Treatment of Osteoarthritis of the Orthopaedic Society of the Chinese Medical Association in 2018; 2. Aged 50 to 75 years; 3. Pain VAS > 3 points.

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

Measure	Time frame
The rate of change of WOMAC scale score;WOMAC scale score decreased from baseline;Pain VAS score for joint pain;	—

Countries

China

Contacts

Public ContactWeng Xisheng

Peking Union Medical College Hospital

pumchww@139.com+86 13501204373

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026